22NW, LP Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$212.3B

Holdings

21

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
ANEBANEBULO PHARMACEUTICALS INC
15,467,300$38.7B18.22%
2
FSTRFOSTER L B CO
1,313,121$35.4B16.67%
3
LDELIFECORE BIOMEDICAL INC
1,254$20.1B9.49%
4
NKTRNEKTAR THERAPEUTICS
331,115$18.8B8.88%
5
SRISTONERIDGE INC
2,105,600$16.0B7.56%
6
MLYSMINERALYS THERAPEUTICS INC
358,325$13.6B6.40%
7
RGNXREGENXBIO INC
923,679$8.9B4.20%
8
CULPCULP INC
1,859,061$8.3B3.91%
9
RZLTREZOLUTE INC
820,653$7.7B3.63%
10
DHXDHI GROUP INC
2,036,988$5.7B2.67%
11
PFXPHENIXFIN CORP
117,885$5.6B2.64%
12
MECMAYVILLE ENGR CO INC
399,890$5.5B2.59%
13
MGTXMEIRAGTX HLDGS PLC
586,519$4.8B2.27%
14
UFIUNIFI INC
977,639$4.7B2.19%
15
CMTCORE MOLDING TECHNOLOGIES IN
222,738$4.6B2.16%
16
AEBIAEBI SCHMIDT HLDG AG
347,840$4.3B2.04%
17
FARMFARMER BROS CO
1,955,526$3.3B1.58%
18
TISITEAM INC
170,187$2.8B1.33%
19
ELDNELEDON PHARMACEUTICALS INC
636,364$1.6B0.78%
20
E2OSTRATA SKIN SCIENCES INC
536,995$1.1B0.52%
21
PMDIPSYCHEMEDICS CORPORATION CMN
276,034$582.4M0.27%